Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 30, 2024 Filed Oct 31, 2024 20:45 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $51.93 | $103,860.00 |
DisclosureSEC source: 0001127602-24-026160 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 114,920 Read SEC document |
| October 30, 2024 Filed Oct 31, 2024 20:45 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 5,300 | $51.90 | $275,070.00 |
DisclosureSEC source: 0001127602-24-026160 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,920 Read SEC document |
| October 30, 2024 Filed Oct 31, 2024 20:45 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 5,300 | $7.96 | $42,188.00 |
DisclosureSEC source: 0001127602-24-026160 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 20:49 UTC |
WIERENGA WENDALLDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 4,452 | $0.00 Strike: $7.37 | $0.00 |
DisclosureSEC source: 0001127602-24-026161 · form4.xml · derivative · entry 3 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,484 Underlying: Common Stock · 4,452 shares Expires 2025-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest and become exercisable as to 5,936 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2016. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 20:49 UTC |
WIERENGA WENDALLDirector
|
SaleCommon Stock | 4,452 | $52.25 | $232,617.00 |
DisclosureSEC source: 0001127602-24-026161 · form4.xml · nonDerivative · entry 2 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,559 Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 20:49 UTC |
WIERENGA WENDALLDirector
|
Exercise / conversionCommon Stock | 4,452 | $7.37 | $32,811.24 |
DisclosureSEC source: 0001127602-24-026161 · form4.xml · nonDerivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 22:45 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,300 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001127602-24-025636 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,200 Underlying: Common Stock · 5,300 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 22:45 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $54.20 | $108,400.00 |
DisclosureSEC source: 0001127602-24-025636 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,920 Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 22:45 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 5,300 | $54.18 | $287,154.00 |
DisclosureSEC source: 0001127602-24-025636 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,920 Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 22:45 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 5,300 | $7.96 | $42,188.00 |
DisclosureSEC source: 0001127602-24-025636 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 20:00 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-025384 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 20:00 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $55.61 | $278,050.00 |
DisclosureSEC source: 0001127602-24-025384 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 20:00 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-025384 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:48 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,300 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001127602-24-024720 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Stock · 5,300 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:48 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 5,300 | $52.09 | $276,077.00 |
DisclosureSEC source: 0001127602-24-024720 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,920 Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:48 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 5,300 | $7.96 | $42,188.00 |
DisclosureSEC source: 0001127602-24-024720 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:48 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $52.11 | $104,220.00 |
DisclosureSEC source: 0001127602-24-024720 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,920 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 21:28 UTC |
Harrington Robert ArthurDirector
|
GrantCommon Stock | 237 | $52.60 | $12,466.20 |
DisclosureSEC source: 0001127602-24-025197 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,753 F1 · kind: Stock award in lieu of cash retainer payment. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 21:27 UTC |
HENDERSON JOHN TDirector
|
GrantCommon Stock | 403 | $52.60 | $21,197.80 |
DisclosureSEC source: 0001127602-24-025196 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,461 F1 · kind: Stock award in lieu of cash retainer payment. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 21:26 UTC |
Kaye Edward M. MDDirector
|
GrantCommon Stock | 237 | $52.60 | $12,466.20 |
DisclosureSEC source: 0001127602-24-025195 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,382 F1 · kind: Stock award in lieu of cash retainer payment. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 21:25 UTC |
WIERENGA WENDALLDirector
|
GrantCommon Stock | 118 | $52.60 | $6,206.80 |
DisclosureSEC source: 0001127602-24-025194 · form4.xml · nonDerivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,559 F1 · kind: Stock award in lieu of cash retainer payment. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 21:24 UTC |
Wysenski NancyDirector
|
GrantCommon Stock | 118 | $52.60 | $6,206.80 |
DisclosureSEC source: 0001127602-24-025193 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,988 F1 · kind: Stock award in lieu of cash retainer payment. Read SEC document |
| September 30, 2024 Filed Sep 30, 2024 22:56 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-024579 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Sep 30, 2024 22:56 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $52.14 | $260,700.00 |
DisclosureSEC source: 0001127602-24-024579 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| September 30, 2024 Filed Sep 30, 2024 22:56 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-024579 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2024 Filed Sep 17, 2024 20:15 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,300 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001127602-24-024083 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,800 Underlying: Common Stock · 5,300 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2024 Filed Sep 17, 2024 20:15 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $56.76 | $113,520.00 |
DisclosureSEC source: 0001127602-24-024083 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,920 Read SEC document |
| September 17, 2024 Filed Sep 17, 2024 20:15 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 5,300 | $56.77 | $300,881.00 |
DisclosureSEC source: 0001127602-24-024083 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,920 Read SEC document |
| September 17, 2024 Filed Sep 17, 2024 20:15 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 5,300 | $7.96 | $42,188.00 |
DisclosureSEC source: 0001127602-24-024083 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:10 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-024077 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:10 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $55.99 | $279,950.00 |
DisclosureSEC source: 0001127602-24-024077 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:10 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-024077 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2024 Filed Sep 9, 2024 20:05 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $21.61 | $0.00 |
DisclosureSEC source: 0001127602-24-023646 · form4.xml · derivative · entry 3 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2030-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant. Read SEC document |
| September 09, 2024 Filed Sep 9, 2024 20:05 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 5,000 | $54.92 | $274,600.00 |
DisclosureSEC source: 0001127602-24-023646 · form4.xml · nonDerivative · entry 2 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,600 Read SEC document |
| September 09, 2024 Filed Sep 9, 2024 20:05 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionCommon Stock | 5,000 | $21.61 | $108,050.00 |
DisclosureSEC source: 0001127602-24-023646 · form4.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:14 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,300 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001127602-24-023334 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,100 Underlying: Common Stock · 5,300 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:14 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 5,300 | $57.02 | $302,206.00 |
DisclosureSEC source: 0001127602-24-023334 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,920 Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:14 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,084 | $56.99 | $118,767.16 |
DisclosureSEC source: 0001127602-24-023334 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,920 Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:14 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 5,300 | $7.96 | $42,188.00 |
DisclosureSEC source: 0001127602-24-023334 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:09 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-023332 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,727 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:09 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $57.03 | $285,150.00 |
DisclosureSEC source: 0001127602-24-023332 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,456 Read SEC document |
| September 03, 2024 Filed Sep 3, 2024 21:09 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 5,000 | $6.67 | $33,350.00 |
DisclosureSEC source: 0001127602-24-023332 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 402,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2024 Filed Sep 3, 2024 21:06 UTC |
Pletcher Brett AEVP, Chief Legal Officer
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 51,039 | $0.00 Strike: $57.08 | $0.00 |
DisclosureSEC source: 0001127602-24-023331 · form4.xml · derivative · entry 2 Pletcher Brett A · CIK 0001739307 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,039 Underlying: Common Stock · 51,039 shares Expires 2034-08-30 F2 · kind: Inducement grant comprised of stock options to purchase shares of common stock subject to time lapse vesting. 25% of the stock options vest on the 1-year anniversary of the grant date and the remaining 75% of the stock options vest in equal monthly installments over the subsequent 3 years to the 1-year anniversary of the grant date, with each installment vesting subject to the grantee's continued employment with the company. Read SEC document |
| August 30, 2024 Filed Sep 3, 2024 21:06 UTC |
Pletcher Brett AEVP, Chief Legal Officer
|
GrantCommon Stock | 33,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023331 · form4.xml · nonDerivative · entry 1 Pletcher Brett A · CIK 0001739307 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,140 F1 · kind: Inducement grant comprised of restricted stock units ("RSUs") that are converted into shares of common stock on a 1:1 basis upon time based vesting. 40% of the RSUs vest on the 1-year anniversary of the grant date, an additional 40% of the RSUs vest on the 2-year anniversary of the grant date, and the remaining 20% of the RSUs vest on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment with the company. Read SEC document |
| August 26, 2024 Filed Aug 26, 2024 20:00 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $21.61 | $0.00 |
DisclosureSEC source: 0001127602-24-022909 · form4.xml · derivative · entry 3 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant. Read SEC document |
| August 26, 2024 Filed Aug 26, 2024 20:00 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 5,000 | $57.26 | $286,300.00 |
DisclosureSEC source: 0001127602-24-022909 · form4.xml · nonDerivative · entry 2 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,600 Read SEC document |
| August 26, 2024 Filed Aug 26, 2024 20:00 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionCommon Stock | 5,000 | $21.61 | $108,050.00 |
DisclosureSEC source: 0001127602-24-022909 · form4.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:00 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,300 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001127602-24-022777 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,400 Underlying: Common Stock · 5,300 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:00 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 5,300 | $56.26 | $298,178.00 |
DisclosureSEC source: 0001127602-24-022777 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,004 Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:00 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 5,300 | $7.96 | $42,188.00 |
DisclosureSEC source: 0001127602-24-022777 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.